chartexchange

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. | Oct 28, 2026 7:30 AM EDT

BOSTON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Tom Civik, Chief Executive Officer and Chairman of Pyxis Oncology, will participate in fireside chats at two upcoming conferences.

Read original article